Metabolomics: An Improved Lipid Profiling Workflow Demonstrates Disrupted Lipogenesis Induced with Drug Treatment in Leukemia Cells

Postery | 2019 | Agilent Technologies | MetabolomicsInstrumentace
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Zaměření
Klinická analýza, Lipidomika
Výrobce
Agilent Technologies
PDF verze ke stažení a čtení
 

Podobná PDF

A New Lipidomics Software Workflow Demonstrates Disrupted Lipogenesis Induced with Drug Treatment in Leukemia Cells
Lipid Profiling Workflow Demonstrates Disrupted Lipogenesis Induced with Drug Treatment in Leukemia Cells
Automated Dual Metabolite+Lipid Cell Sample Prep as a Component of an LC/HRMS-based Workflow to Elucidate the Molecular Response to Drug Treatment
Illuminating the Cellular and Molecular Response to Drug Treatment by Combining Bioenergetic Measurements with Untargeted Metabolomics